BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24857146)

  • 21. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
    Le Tourneau C; Kamal M; Tsimberidou AM; Bedard P; Pierron G; Callens C; Rouleau E; Vincent-Salomon A; Servant N; Alt M; Rouzier R; Paoletti X; Delattre O; Bièche I
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working group.
    Geiersbach KB; Chen H; Emmadi R; Haskell GT; Lu X; Liu YJ; Swisshelm K
    Cancer Genet; 2020 Jun; 244():11-20. PubMed ID: 32087595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision cancer medicine: the future is now, only better.
    Tsimberidou AM; Eggermont AM; Schilsky RL
    Am Soc Clin Oncol Educ Book; 2014; ():61-9. PubMed ID: 24857061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
    Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
    Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
    [No Abstract]   [Full Text] [Related]  

  • 25. Personalized medicine for metastatic breast cancer.
    Chen TW; Bedard PL
    Curr Opin Oncol; 2013 Nov; 25(6):615-24. PubMed ID: 24097103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Diagnosis and Management of Breast Cancer.
    McDonald ES; Clark AS; Tchou J; Zhang P; Freedman GM
    J Nucl Med; 2016 Feb; 57 Suppl 1():9S-16S. PubMed ID: 26834110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
    Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
    Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a personalized treatment of head and neck cancer.
    Gross AM; Cohen EE
    Am Soc Clin Oncol Educ Book; 2015; ():28-32. PubMed ID: 25993138
    [No Abstract]   [Full Text] [Related]  

  • 29. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
    Albin N; Mc Leer A; Sakhri L
    Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steps forward for cancer precision medicine.
    Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
    Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative genomic analysis of primary tumors and metastases in breast cancer.
    Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
    Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic profiling of breast cancers.
    Curtis C
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in clinical research for metastatic breast cancer.
    Dogan S; Andre F; Arnedos M
    Curr Opin Oncol; 2013 Nov; 25(6):625-9. PubMed ID: 24097109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successes and limitations of targeted cancer therapy in melanoma.
    Romano E; Michielin O
    Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision medicine in breast cancer.
    Naito Y; Urasaki T
    Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Therapy of Breast Cancer.
    Janni W
    Oncol Res Treat; 2016; 39(3):100-1. PubMed ID: 27031668
    [No Abstract]   [Full Text] [Related]  

  • 39. Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.
    Henry NL; Bedard PL; DeMichele A
    Am Soc Clin Oncol Educ Book; 2017; 37():106-115. PubMed ID: 28561710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparing pathology for precision medicine: challenges and opportunities.
    Kaul KL
    Virchows Arch; 2017 Aug; 471(2):141-146. PubMed ID: 28512674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.